Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119220) titled 'A Pilot Study on Gut Microbiota-Derived Metabolic Signatures for Early Detection of Heart Failure' on Feb. 24.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Zhejiang Provincial People's Hospital
Condition:
Heart Failure
Intervention:
Health:None
HF1:None
HF2:None
HF3:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-01
Target Sample Size: Health:100;HF1:100;HF2:100;HF3:100;HF4:100;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=308805
Published by HT Digital Content Services with p...